Abstract
Among the strategies that can lead to the discovery of new drugs, the identification and use of privileged structures, molecular fragments that are able to interact with more than one target, gained particular attention, in an attempt to find new drugs in a shorter time with respect to other strategies. These structures, that have been identified mainly by empirical observations, can target only a given protein family, or can be able to interact with more, unrelated targets. This review deals with structures not covered in recent papers on this topic, and emphasizes the importance of understanding the structure-target relationships, that confer the privileged status
Keywords: Privileged structures, drug discovery, carbohydrates, benzodiazepines, biphenyls, pirrolynones
Related Journals
Current Bioactive Compounds
Current Chinese Science
Current Medicinal Chemistry
Combinatorial Chemistry & High Throughput Screening
Anti-Cancer Agents in Medicinal Chemistry
Current Computer-Aided Drug Design
Current Topics in Chemistry
Current Catalysis
Current Analytical Chemistry
Current Chinese Chemistry
Related Books
A Journey Through Water: A Scientific Exploration of The Most Anomalous Liquid on Earth
Advances in Mathematical Chemistry and Applications
Advances in Mathematical Chemistry and Applications
Advances in Mathematical Chemistry and Applications Volume 1 (Revised Edition)
Advances in Organic Synthesis
Advances in Organic Synthesis
Advances in Organic Synthesis
Advances in Organic Synthesis
Advances in Organic Synthesis
Advances in Organic Synthesis